FAS and neoplasm: IFN-γ can be controlled by regulating the Fas/FasL expression of tumor cells and enhancing the sensitivity of tumor cells to the Fas-mediated apoptosis pathway, thereby reducing the ability of tumor cells to evade the immune system attack and, accordingly, inhibiting the malignant proliferation of tumor cells [14–16].